Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Precancerous Conditions 1Colorectal Neoplasms 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Specimen Handling 3Biopsy 3Endoscopy, Gastrointestinal 2obeticholic acid 1Surveys and Questionnaires 1Sigmoidoscopy 1Gastroscopy 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Eflornithine 1Curcumin 1Colonoscopy 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenomatous Polyposis Coli × Eflornithine × Clear all
NCT00033371 2020-09-29

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Completed
205 enrolled 16 charts
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡